Melville H. Moby-Dick; or, The Whale. 4 ed. New York, New York: Penguin Group; 2003. p. 3.

Global and regional tourism performance 2024 [Available from: https://www.unwto.org/tourism-data/global-and-regional-tourism-performance. Accessed 3 Jul 2024.

Martinson ML, Lapham J. Prevalence of Immunosuppression Among US Adults. JAMA. 2024;331(10):880–2.

PubMed  PubMed Central  Google Scholar 

LaRocque RC, Rao SR, Lee J, Ansdell V, Yates JA, Schwartz BS, et al. Global TravEpiNet: a national consortium of clinics providing care to international travelers–analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009–2011. Clin Infect Dis. 2012;54(4):455–62.

PubMed  Google Scholar 

Brown AB, Miller C, Hamer DH, Kozarsky P, Libman M, Huits R, et al. Travel-Related Diagnoses Among U.S. Nonmigrant Travelers or Migrants Presenting to U.S. GeoSentinel Sites - GeoSentinel Network, 2012–2021. MMWR Surveill Summ. 2023;72(7):1–22.

PubMed  PubMed Central  Google Scholar 

Mikati T, Griffin K, Lane D, Matasar M, Shah MK. International travel patterns and travel risks for stem cell transplant recipients. J Travel Med. 2015;22(1):39–47.

PubMed  Google Scholar 

Mikati T, Taur Y, Seo SK, Shah MK. International travel patterns and travel risks of patients diagnosed with cancer. J Travel Med. 2013;20(2):71–7.

PubMed  Google Scholar 

Schwartz BS, Rosen J, Han PV, Hynes NA, Hagmann SH, Rao SR, et al. Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg. 2015;93(5):1110–6.

PubMed  PubMed Central  Google Scholar 

Kotton CN, Kroger AT, Freedman DO. Travelers with additional considerations: Immunocompromised travelers. CDC Yellow Book 2024: Health Information for International Travel. 2024 ed: Oxford University Press; 2024.

Radcliffe C, Kotton CN. En Garde or On Board? Travel Medicine for Immunocompromised Patients in the COVID-19 Era. Ann Intern Med. 2024;177(5):667–9.

PubMed  Google Scholar 

Destinations | Traveler's Health 2024 [Available from: https://wwwnc.cdc.gov/travel/destinations/list. Accessed  6 Aug 2024.

Meningococcal Vaccine Recommendations 2024 [updated November 30, 2023. Available from: https://www.cdc.gov/vaccines/vpd/mening/hcp/recommendations.html.

Freedman DO, Kotton CN. Three RSV vaccines now recommended for many older adults; what about travellers? J Travel Med. 2024. p. taae100. https://doi.org/10.1093/jtm/taae100.

Bierbrier R, Javelle E, Norman FF, Chen LH, Bottieau E, Schwartz E, et al. Chikungunya infection in returned travellers: results from the geosentinel network, 2005–2020. J Travel Med. 2024;31(2):taae005. https://doi.org/10.1093/jtm/taae005.

Chikungunya Vaccine Information for Healthcare Providers [updated May 20, 2024. Available from: https://www.cdc.gov/chikungunya/hcp/vaccine/index.html.

Collins JP, Ryan ET, Wong KK, Daley MF, Ratner AJ, Appiah GD, et al. Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022. MMWR Recomm Rep. 2022;71(2):1–8.

PubMed  PubMed Central  Google Scholar 

Perry RT, Plowe CV, Koumaré B, Bougoudogo F, Kotloff KL, Losonsky GA, et al. A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. Bull World Health Organ. 1998;76(1):63–71.

PubMed  PubMed Central  Google Scholar 

Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(10):1080–8.

PubMed  PubMed Central  Google Scholar 

Cholera 2023 [updated December 11, 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/cholera.

Paz-Bailey G, Adams L, Wong JM, Poehling KA, Chen WH, McNally V, et al. Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021. MMWR Recomm Rep. 2021;70(6):1–16.

PubMed  PubMed Central  Google Scholar 

Increased Risk of Dengue Virus Infections in the United States: CDC Health Alert Network; 2024 [updated June 25, 2024. Available from: https://emergency.cdc.gov/han/2024/han00511.asp.

Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep. 2020;69(5):1–38.

PubMed  PubMed Central  Google Scholar 

Askling HH, Rombo L, van Vollenhoven R, Hallén I, Thörner Å, Nordin M, et al. Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study. Travel Med Infect Dis. 2014;12(2):134–42.

PubMed  Google Scholar 

Garcia Garrido HM, Wieten RW, Grobusch MP, Goorhuis A. Response to Hepatitis A Vaccination in Immunocompromised Travelers. J Infect Dis. 2015;212(3):378–85.

PubMed  Google Scholar 

Adati EM, da Silva PM, Sumita LM, Rodrigues MO, Zanetti LP, Dos Santos ACF, et al. Poor response to hepatitis A vaccination in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2020;22(3):e13258.

PubMed  Google Scholar 

Jeon HJ, Ro H, Jeong JC, Koo TY, Han M, Min SI, et al. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis. 2014;16(3):511–5.

PubMed  Google Scholar 

Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation. 2001;72(2):272–6.

PubMed  Google Scholar 

Rosdahl A, Herzog C, Frösner G, Norén T, Rombo L, Askling HH. An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression - A prospective, open-label, multi-center study. Travel Med Infect Dis. 2018;21:43–50.

PubMed  Google Scholar 

Hills SL, Walter EB, Atmar RL, Fischer M, Group AJEVW. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2019;68(2):1–33.

Qi ZL, Sun LY, Bai J, Zhuang HZ, Duan ML. Japanese encephalitis following liver transplantation: A rare case report. World J Clin Cases. 2020;8(2):337–42.

PubMed  PubMed Central  Google Scholar 

Assawawiroonhakarn S, Apiwattanakul N, Pakakasama S, Hongeng S, Anurathapan U, Yoksan S, et al. Immunogenicity of Vero Cell Culture-derived Japanese Encephalitis Vaccine in Pediatric and Young Hematopoietic Stem Cell Transplantation Recipients. Pediatr Infect Dis J. 2021;40(3):264–8.

PubMed  Google Scholar 

Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. N Engl J Med. 2022;387(19):1783–93.

PubMed  Google Scholar 

Rivers C, Watson C, Phelan AL. The resurgence of Mpox in Africa. JAMA. 2024;332(13):1045–1046. https://doi.org/10.1001/jama.2024.17829.

Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(22):734–42.

PubMed  PubMed Central  Google Scholar 

Dalton AF, Diallo AO, Chard AN, Moulia DL, Deputy NP, Fothergill A, et al. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(20):553–8.

PubMed  PubMed Central  Google Scholar 

Al Jurdi A, Kotton CN. Monkeypox in Transplant Recipients: No Breaks Between Outbreaks. Transplantation. 2022;106(11):e512–3.

PubMed  Google Scholar 

Morino E, Mine S, Tomita N, Uemura Y, Shimizu Y, Saito S, et al. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults. NEJM Evid. 2024;3(3):EVIDoa2300290.

PubMed  Google Scholar 

Bigouette JP, Henderson E, Traoré MA, Wassilak SGF, Jorba J, Mahoney F, et al. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022. MMWR Morb Mortal Wkly Rep. 2023;72(14):366–71.

PubMed  PubMed Central  Google Scholar 

Kidd S, Clark T, Routh J, Cineas S, Bahta L, Brooks O. Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(49):1327–30.

PubMed  PubMed Central  Google Scholar 

Brandão LGP, Santoro-Lopes G, Oliveira SS, da Silva EE, do Brasil PEAA. Seroprevalence of antibodies against the three serotypes of poliovirus and IPV vaccine response in adult solid organ transplant candidates. Vaccine. 2018;36(31):4681–6.

Rao AK, Briggs D, Moore SM, Whitehill F, Campos-Outcalt D, Morgan RL, et al. Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(18):619–27.

PubMed  PubMed Central  Google Scholar 

Kopel E, Oren G, Sidi Y, David D. Inadequate antibody response to rabies vaccine in immunocompromised patient. Emerg Infect Dis. 2012;18(9):1493–5.

PubMed  PubMed Central  Google Scholar 

Thisyakorn U, Pancharoen C, Ruxrungtham K, Ubolyam S, Khawplod P, Tantawichien T, et al. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clin Infect Dis. 2000;30(1):218.

PubMed  Google Scholar 

Hills SL, Poehling KA, Chen WH, Staples JE. Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023. MMWR Recomm Rep. 2023;72(5):1–29.

PubMed  PubMed Central  Google Scholar 

Velay A, Janssen-Langenstein R, Kremer S, Laugel E, Lutz M, Pierson AL, et al. Tick-Borne Encephalitis in Pregnant Woman and Long-Term Sequelae. Emerg Infect Dis. 2023;29(3):669–71.

PubMed  PubMed Central  Google Scholar 

Knight A, Pauksens K, Nordmark G, Kumlien E. Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab. Rheumatology (Oxford). 2017;56(5):855–6.

PubMed  Google Scholar 

Steininger PA, Bobinger T, Dietrich W, Lee DH, Knott M, Bogdan C, et al. Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention. Open Forum Infect Dis. 2017;4(4):ofx204.

PubMed  PubMed Central  Google Scholar 

Christoph R, Giovanni A, Arne S, Sebastian V, Gerhard D, Angelika M, et al. Immunogenicity of tick-borne-encephalitis-virus-(TBEV)-vaccination and impact of age on humoral and cellular TBEV-specific immune responses in patients with rheumatoid arthritis. Vaccine. 2024;42(4):745–52.